Pharming

Pharming PHAR Stock

$12.47   -0.992063%
Add to favorites
Market Cap
$882.96M
LOW - HIGH [24H]
$12.47 - $12.74
VOLUME [24H]
$8.19K
P/E Ratio
38.98
Earnings per share
$0.32
ISIN
US71716E1055
Price   Prediction

Pharming Price Chart

Sorry, that's all we've gotfor now...

Pharming (PHAR) stock price today is 12.48 USD on Tech Market Middle (-0.99% on the day). Updated .

Pharming PHAR Financial and Trading Overview

Pharming stock price 12.48 USD
Previous Close 12.95 USD
Open 12.69 USD
Bid 17.34 USD x 100
Ask 12.17 USD x 100
Day's Range 12.49 - 13.07 USD
52 Week Range 9.11 - 21.34 USD
Volume 5.07K USD
Avg. Volume 21.95K USD
Market Cap 891.8M USD
Beta (5Y Monthly) 0.047
PE Ratio (TTM) 39.375004
EPS (TTM) 0.32 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 35.7 USD

PHAR Valuation Measures

Enterprise Value 786.81M USD
Trailing P/E 39.375004
Forward P/E 70
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 2.3058999
Price/Book (mrq) 2.9577465
Enterprise Value/Revenue 2.034
Enterprise Value/EBITDA 13.801

Trading Information

Pharming Stock Price History

Beta (5Y Monthly) 0.047
52-Week Change -22.34%
S&P500 52-Week Change 13.32%
52 Week High 21.34 USD
52 Week Low 9.11 USD
50-Day Moving Average 10.96 USD
200-Day Moving Average 13.45 USD

PHAR Share Statistics

Avg. Volume (3 month) 21.95K USD
Avg. Daily Volume (10-Days) 14.83K USD
Shares Outstanding 70.78M
Float 67.32M
Short Ratio 1.86
% Held by Insiders 0%
% Held by Institutions 0.12%
Shares Short 25.78K
Short % of Float 0.040%
Short % of Shares Outstanding 0.040%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 6.25%
Operating Margin (ttm) 12.77%
Gross Margin 87.67%
EBITDA Margin 14.74%

Management Effectiveness

Return on Assets (ttm) 6.36%
Return on Equity (ttm) 8.69%

Income Statement

Revenue (ttm) 386.75M USD
Revenue Per Share (ttm) 5.17 USD
Quarterly Revenue Growth (yoy) 20.80%
Gross Profit (ttm) 339.06M USD
EBITDA 57.01M USD
Net Income Avi to Common (ttm) 24.18M USD
Diluted EPS (ttm) 0.32
Quarterly Earnings Growth (yoy) 197.10%

Balance Sheet

Total Cash (mrq) 189.56M USD
Total Cash Per Share (mrq) 2.77 USD
Total Debt (mrq) 114.51M USD
Total Debt/Equity (mrq) 39.32 USD
Current Ratio (mrq) 3.225
Book Value Per Share (mrq) 4.26

Cash Flow Statement

Operating Cash Flow (ttm) 35.37M USD
Levered Free Cash Flow (ttm) 42.47M USD

Profile of Pharming

Country United States
State N/A
City Leiden
Address Darwinweg 24
ZIP 2333 CR
Phone 31 71 524 7400
Website https://www.pharming.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 407

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3Kd inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3Kd inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

Q&A For Pharming Stock

What is a current PHAR stock price?

Pharming PHAR stock price today per share is 12.48 USD.

How to purchase Pharming stock?

You can buy PHAR shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Pharming?

The stock symbol or ticker of Pharming is PHAR.

Which industry does the Pharming company belong to?

The Pharming industry is Biotechnology.

How many shares does Pharming have in circulation?

The max supply of Pharming shares is 70.78M.

What is Pharming Price to Earnings Ratio (PE Ratio)?

Pharming PE Ratio is 38.98438000 now.

What was Pharming earnings per share over the trailing 12 months (TTM)?

Pharming EPS is 0.32 USD over the trailing 12 months.

Which sector does the Pharming company belong to?

The Pharming sector is Healthcare.

Pharming PHAR included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24613.22 USD —
-2.08
4.52B USD — 24572.01 USD — 24882.04 USD — — 4.52B USD —
us US Tech Global Market Composite NQGM US 1884.39 USD —
-2.76
— — 1882.26 USD — 1913 USD — — — —
us US Tech Health Care IXHC US 1356.2 USD —
-0.88
— — 1355.82 USD — 1374 USD — — — —
$2.23T
Total marketcap
$76.33B
Total volume
BTC 58.62%   •   ETH 10.02%
Dominance
Select currency